Stocktoria
OptimizeRx Corp OPRX
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2005-05-18
OptimizeRx Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $109.4M | $92.1M | $71.5M | — | $62.5M |
| Gross profit | $73.6M | $59.4M | $42.9M | — | $39.0M |
| R&D expense | $0 | $0 | — | — | — |
| SG&A expense | — | — | — | — | $33.5M |
| Operating income | $11.7M | -$13.7M | -$26.4M | — | -$12.3M |
| Interest expense | — | — | $1.5M | — | — |
| Income tax | $1.8M | $725,000 | -$7.6M | — | — |
| Net income | $5.1M | -$20.1M | -$17.6M | — | -$11.4M |
| EPS (diluted) | $0.27 | $-1.10 | $-1.03 | $-0.21 | $-0.64 |
| Operating cash flow | $18.7M | $4.9M | -$7.2M | — | $10.7M |
| Free cash flow | $18.7M | $4.8M | -$7.3M | — | $10.6M |
| Cash & equivalents | $23.4M | $13.4M | $13.9M | $9.8M | $18.2M |
| Total assets | $176.9M | $171.2M | $183.4M | $121.3M | $134.7M |
| Total liabilities | $48.6M | $54.2M | $56.8M | $5.5M | $8.5M |
| Shareholders' equity | $128.3M | $117.0M | $126.6M | $115.8M | $126.1M |
Source: SEC EDGAR filings · CIK 0001448431 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.